🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to characterize the effects of 85 days treatme...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05-20
Trial ID
NCT02410499
Treatments Being Tested
The purpose of this study is to evaluate the effect of MLN1202 on arterial ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-04
Trial ID
NCT02388971
The objective of the study is to investigate the safety, pharmacokinetics, ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02426021
Treatments Being Tested
The purpose of this study is to determine the initial safety profile and in...
Status
Terminated
Location
University of Arizona Cancer Center
Start Date
2016-06-22
Trial ID
NCT02723006
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such MLN1202, can block tumor growth in d...
Status
Completed
Location
Glendale Memorial Hospital Comprehensive Cancer Center
Start Date
2010-03
Trial ID
NCT01015560
Treatments Being Tested
This was a phase 2a study of MLN1202 to determine safety, tolerability and ...
Status
Completed
Location
Multiple Locations
Start Date
2005-05
Trial ID
NCT01199640
Treatments Being Tested
This study is a, randomized, double-blind, placebo-controlled phase 2a tria...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT00715169